Bicocca Open Archive

Logo unimib boa
ARCANGELI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.985
NA - Nord America 7.868
EU - Europa 4.118
SA - Sud America 1.123
AF - Africa 105
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.207
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.720
SG - Singapore 5.037
HK - Hong Kong 1.318
VN - Vietnam 1.123
CN - Cina 1.072
IT - Italia 977
BR - Brasile 911
RU - Federazione Russa 847
IE - Irlanda 620
DE - Germania 609
SE - Svezia 366
GB - Regno Unito 174
UA - Ucraina 138
AR - Argentina 105
FR - Francia 99
KR - Corea 91
CA - Canada 76
ID - Indonesia 74
IN - India 64
FI - Finlandia 61
MX - Messico 59
NL - Olanda 52
BD - Bangladesh 49
ZA - Sudafrica 48
AT - Austria 38
EC - Ecuador 37
PL - Polonia 33
TR - Turchia 28
ES - Italia 22
IQ - Iraq 21
JP - Giappone 20
EG - Egitto 18
CO - Colombia 17
CH - Svizzera 14
CL - Cile 14
SA - Arabia Saudita 13
CZ - Repubblica Ceca 12
DK - Danimarca 12
MA - Marocco 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
UZ - Uzbekistan 11
LT - Lituania 10
PK - Pakistan 9
UY - Uruguay 9
TN - Tunisia 8
VE - Venezuela 8
PE - Perù 6
AL - Albania 5
GR - Grecia 5
KE - Kenya 5
KZ - Kazakistan 5
MY - Malesia 5
PT - Portogallo 5
BO - Bolivia 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
RO - Romania 4
AU - Australia 3
AZ - Azerbaigian 3
BE - Belgio 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
NP - Nepal 3
SC - Seychelles 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AM - Armenia 2
ET - Etiopia 2
HN - Honduras 2
LB - Libano 2
LV - Lettonia 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
GA - Gabon 1
GT - Guatemala 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
TH - Thailandia 1
TO - Tonga 1
TW - Taiwan 1
Totale 22.207
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.313
Fairfield 1.048
Singapore 1.001
Ann Arbor 823
Ashburn 806
Dublin 613
Frankfurt am Main 448
Woodbridge 429
Seattle 413
Wilmington 405
Ho Chi Minh City 361
Santa Clara 360
Houston 345
Cambridge 341
Hanoi 260
Princeton 237
Milan 224
Hefei 218
New York 215
Los Angeles 152
Beijing 140
Moscow 132
Chandler 122
Altamura 110
Lawrence 108
Dallas 91
Seoul 91
Dearborn 89
Jacksonville 87
São Paulo 85
The Dalles 78
Munich 76
Chicago 75
Buffalo 72
Rome 70
San Diego 69
Nanjing 67
Da Nang 43
Andover 41
Guangzhou 40
Jakarta 40
Rio de Janeiro 38
Shanghai 38
Salt Lake City 36
London 32
Toronto 31
Haiphong 29
Warsaw 28
Dong Ket 26
Ottawa 26
Nuremberg 25
Biên Hòa 24
Hebei 24
Helsinki 24
Shenyang 24
Ha Long 23
Nanchang 23
Belo Horizonte 20
Changsha 19
Johannesburg 19
Lappeenranta 19
Ninh Bình 19
Tokyo 19
Vienna 19
Brooklyn 18
Curitiba 18
Can Tho 17
Turku 17
Xi'an 17
Campinas 16
Mexico City 16
Stockholm 16
Elk Grove Village 15
Jiaxing 15
Phoenix 15
Quận Một 15
Tampa 15
Thái Nguyên 15
Bắc Ninh 14
Boston 13
Cape Town 13
Hải Dương 13
Jinan 13
Kent 13
Pune 13
Quận Bình Thạnh 13
Vũng Tàu 13
Brasília 12
Lissone 12
Sterling 12
Zurich 12
Chennai 11
Fremont 11
Guayaquil 11
Monza 11
Phủ Lý 11
Porto Alegre 11
Sorocaba 11
Tianjin 11
Council Bluffs 10
Totale 12.812
Salva come PNG Salva come JPEG
Nome #
Effetti immunologici della radioterapia 474
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 429
The ‘Liaisons dangereuses’ Between Lung Cancer and Interstitial Lung Diseases: A Focus on Acute Exacerbation 414
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: A secondary analysis from a randomized study 377
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 337
Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours 305
Single-Isocenter Linac-Based Radiosurgery for Brain Metastases with Coplanar Arcs: A Dosimetric and Clinical Analysis 297
International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study 297
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 296
Extreme hypofractionation for early prostate cancer: Biology meets technology 295
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 293
Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: A further step toward new evidence 292
Moderate hypofractionation for prostate cancer 288
A Systematic Review of Radical Cystectomy Versus Organ Preserving Trimodal Therapy in Muscle-Invasive Bladder Cancer 285
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 285
Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture? 281
Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study 281
Re-irradiation for esophageal cancer 281
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 281
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era 279
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review 274
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 250
Guidelines on prostate carcinoma - AIRO, 2016 247
Stereotactic Body Radiation Therapy With Ablative Dose on Liver Metastases: Radiation-induced Liver Disease (RILD) and Toxicity Assessment 246
Dose-escalated Radiotherapy for Stage III Unresectable Non-small Cell Lung Cancer: Have We Come to a Standstill? 242
Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 228
Optimal scheduling of hypofractionated radiotherapy for localized prostate cancer: A systematic review and metanalysis of randomized clinical trials 224
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy 212
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 209
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 209
« Augmented radiotherapy » in the management of high-risk prostate cancer (PCa): A systematic review 200
Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study 199
Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysis 177
Stereotactic Body Radiation Therapy for Prostate Cancer is Getting Mature: 10-Year Outcomes From 3 Prospective Trials 172
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group 170
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 168
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 166
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey 164
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials 163
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer 162
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 162
Moderate hypofractionation in high-risk, organ-confined prostate cancer: Final results of a phase III randomized trial 159
Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations 157
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial 154
Phase I-II study of intraoperative radiation therapy (IORT) after radical prostatectomy for prostate cancer 152
Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer 151
GUROPA survey: genito-urinary radiation oncology prescription attitudes 148
Management of patients with extensive small-cell lung cancer in the immunotherapy era: an Italian consensus through a Delphi approach 147
Hypofractionated radiotherapy for organ-confined prostate cancer: Is less more? 147
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area 146
Postoperative Hypofractionated Radiotherapy for Prostate Cancer 145
DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans 145
Epidemiology of prostate cancer and treatment remarks. 143
1539 poster TUMOR CONTROL PROBABILITY IN STEREOTACTIC RADIO-SURGERY FOR BRAIN METASTASES 143
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial 140
In vivo dosimetry of total body irradiation patients: A 10 year retrospective analysis 139
Synchronized Contrast-Enhanced 4DCT Simulation for Target Volume Delineation in Abdominal SBRT 139
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC) 139
Long-term outcomes of volume de-escalation for breast nodal irradiation 138
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer 137
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO) 136
Mathematical Model for Evaluating Incidence of Acute Rectal Toxicity During Conventional or Hypofractionated Radiotherapy Courses for Prostate Cancer 136
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 136
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience 136
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. 135
Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking 135
Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer 133
EORTC radiation proctitis-specific quality of life module - pretesting in four European countries 133
Short-term pain control after palliative radiotherapy for uncomplicated bone metastases: a prospective cohort study 132
Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer 132
Dosimetric and Clinical Prognostic Factors in Single-Isocenter Linac-Based Stereotactic Radiotherapy for Brain Metastases 131
Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC 131
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity 131
Lexicographic optimization-based planning for stereotactic radiosurgery of brain metastases 130
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 130
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer 130
Safety culture to improve accidental event reporting in radiotherapy 130
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I 129
Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed 129
Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy? 127
Updated Results and Pattern of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer 127
Ablative Radiation Therapy for Unfavorable Prostate Tumors (ABRUPT): Preliminary Analysis of Toxicity and Quality of Life from a Prospective Study 126
Clinical and Dosimetric Predictors of Acute Toxicity After a 4-Week Hypofractionated External Beam Radiotherapy Regimen for Prostate Cancer: Results From a Multicentric Prospective Trial 125
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review. 125
10-yr Results of Moderately Hypofractionated Postoperative Radiotherapy for Prostate Cancer Focused on Treatment Related Toxicity 124
A critical review on oligometastatic disease: a radiation oncologist’s perspective 123
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 123
Review and uses of stereotactic body radiation therapy for oligometastases 123
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease 123
Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control 120
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments 120
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study 119
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: a potential comparison bias 119
Hypofractionation and Stereotactic Treatment: Clinical Data 118
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 118
Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI 117
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery 117
From radiobiology to technology: what is changing in radiotherapy for prostate cancer 117
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature 116
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 116
Totale 18.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021960 0 0 0 0 0 137 150 199 105 135 115 119
2021/20221.056 83 133 115 49 27 53 42 178 41 35 88 212
2022/20231.648 275 484 194 75 69 271 30 56 100 15 48 31
2023/20241.502 30 23 34 144 164 358 385 29 169 26 32 108
2024/20258.242 148 583 159 142 278 93 513 192 525 733 2.408 2.468
2025/20265.363 1.184 992 875 1.209 980 123 0 0 0 0 0 0
Totale 22.986